868241-48-9 Usage
General Description
2,2-Difluoropropylamine hydrochloride is a chemical compound with the molecular formula C3H8F2NCl. It is a derivative of propanamine, containing two fluorine atoms and a hydrochloride salt. 2,2-Difluoropropylamine hydrochloride is commonly used in pharmaceutical and chemical research as a building block in the synthesis of various organic compounds, particularly in the development of new drugs. It plays a crucial role in the creation of fluorinated organic molecules, which have unique properties and are utilized in a wide range of applications. Its structure and properties make it a valuable tool for scientists and researchers in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 868241-48-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,8,2,4 and 1 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 868241-48:
(8*8)+(7*6)+(6*8)+(5*2)+(4*4)+(3*1)+(2*4)+(1*8)=199
199 % 10 = 9
So 868241-48-9 is a valid CAS Registry Number.
InChI:InChI=1/C3H7F2N.ClH/c1-3(4,5)2-6;/h2,6H2,1H3;1H
868241-48-9Relevant articles and documents
Discovery of 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)- 6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8-(5H)-one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity
Dow, Robert L.,Carpino, Philip A.,Hadcock, John R.,Black, Shawn C.,Iredale, Philip A.,DaSilva-Jardine, Paul,Schneider, Steven R.,Paight, Ernest S.,Griffith, David A.,Scott, Dennis O.,O'Connor, Rebecca E.,Nduaka, Chudy I.
supporting information; experimental part, p. 2652 - 2655 (2010/03/03)
We report the design, synthesis, and structure-activity relationships of novel bicyclic lactam-based cannabinoid type 1 (CB1) receptor antagonists. Members of these series are potent, selective antagonists in in vitro/in vivo efficacy models of CB1 antagonism and exhibit robust oral activity in rodent models of food intake. These efforts led to the identification of 19d, which has been advanced to human clinical trials for weight management.